ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Antibe Therapeutics Inc

Antibe Therapeutics Inc (ATE)

0,295
0,00
(0,00%)
Geschlossen 01 Februar 10:12PM

Echtzeit-Diskussionen und Handelsideen: Handeln Sie mit Zuversicht mit unserer leistungsstarken Plattform.

Wichtige Statistiken und Details

Current Price
0,295
Gebot
0,09
Fragen
0,09
Volumen
-
0,00 Tagesbereich 0,00
0,15 52-Wochen-Bereich 1,08
Handelsende
0,295
Handelsbeginn
-
Letzte Trade
Letzter Handelszeitpunkt
Durchschnittliches Volumen (3 Mio.)
-
Finanzvolumen
-
VWAP
-

ATE Neueste Nachrichten

Antibe Announces Appointment of Receiver

Antibe Therapeutics Inc. (“Antibe” or the “Company”) (TSX: ATE) announced that the Company’s request for an extension of its previously announced stay of proceedings under the Companies’...

Antibe Provides Update on CCAA Proceedings

Antibe Therapeutics Inc. (“Antibe” or the “Company”) (TSX: ATE) announced that the Company sought an extension of its previously announced stay of proceedings (“Stay”) under the Companies’...

Antibe Announces TSX Delisting Review

Antibe Therapeutics Inc. (“Antibe” or the “Company”) (TSX: ATE) announced that the Toronto Stock Exchange (“TSX”) is reviewing the eligibility for continued listing on the TSX of the securities...

Antibe Announces Granting of Initial Order Under Companies' Creditors Arrangement Act

Antibe Therapeutics Inc. (“Antibe” or the “Company”) (TSX: ATE, OTCQX: ATBPF) announced that its previously announced application for an Initial Order under the Companies' Creditors Arrangement...

Antibe to File an Application for an Initial Order Under Companies' Creditors Arrangement Act

Antibe Therapeutics Inc. (“Antibe” or the “Company”) (TSX: ATE, OTCQX: ATBPF) announced that it intends to file an application today with the Ontario Superior Court of Justice (Commercial List...

Antibe Announces FDA Clinical Hold on Otenaproxesul and Legal Action by Nuance

Antibe Therapeutics Inc. (“Antibe” or the “Company” TSX: ATE, OTCQX: ATBPF) today announced that it received verbal notice on the afternoon of March 28, 2024 from the U.S. Food and Drug...

Antibe to Present Otenaproxesul PK/PD Results at the ASRA Pain Medicine Meeting

- The American Society of Regional Anesthesia and Pain Medicine is the largest subspecialty medical society in anesthesiology Antibe Therapeutics Inc. (TSX: ATE, OTCQX: ATBPF), a clinical-stage...

Antibe to Present Otenaproxesul PK/PD Results at the American Academy of Pain Medicine Meeting

- AAPM is the primary organization for pain medicine physicians in the U.S. Antibe Therapeutics Inc. (TSX: ATE, OTCQX: ATBPF), a clinical-stage biotechnology company leveraging its hydrogen...

Antibe Announces Unfavorable Decision in Arbitration With Nuance Pharma

Antibe Therapeutics Inc. (TSX: ATE, OTCQX: ATBPF), a clinical-stage biotechnology company leveraging its hydrogen sulfide platform to target pain and inflammation, today announced that the...

Antibe Reports Q3 2024 Interim Financial and Operating Results

- Successful PK/PD study confirms liver safety, sets stage for upgraded Phase II trial launch next month - Phase II trial enhancements include placebo arm, increased sample size and adaptive...

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
1000.2950.2950.29500CS
4000.2950.2950.29500CS
12000.2950.2950.29500CS
26000.2950.2950.29500CS
52-0.735-71.3592233011.031.080.15330670.44322364CS
156-0.355-54.61538461540.651.230.15339240.6006697CS
260-0.12-28.91566265060.4157.520.15875901.85703391CS

ATE - Frequently Asked Questions (FAQ)

What is the current Antibe Therapeutics share price?
The current share price of Antibe Therapeutics is $ 0,295
What is the 1 year trading range for Antibe Therapeutics share price?
Antibe Therapeutics has traded in the range of $ 0,15 to $ 1,08 during the past year
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
ESMEuro Sun Mining Inc
$ 0,05
(42,86%)
942,7k
SCYScandium International Mining Corp
$ 0,03
(20,00%)
1,01M
APLIAppili Therapeutics Inc
$ 0,035
(16,67%)
3k
AUMNGolden Minerals Company
$ 0,125
(13,64%)
16k
SVBSilver Bull Resources Inc
$ 0,13
(13,04%)
9,26k
RTGRTG Mining Inc
$ 0,02
(-33,33%)
38k
BABYElse Nutrition Holdings Inc
$ 0,02
(-20,00%)
194,25k
FSYForsys Metals Corp
$ 0,465
(-16,96%)
1,34M
SFDNXT Energy Solutions Inc
$ 0,21
(-12,50%)
19,95k
DIAMStar Diamond Corporation
$ 0,035
(-12,50%)
106,49k
ENBEnbridge Inc
$ 62,84
(-2,47%)
8,96M
CNQCanadian Natural Resources Ltd
$ 44,13
(-1,50%)
6,76M
BMOBank of Montreal
$ 143,94
(-0,20%)
6,74M
GLOGlobal Atomic Corporation
$ 0,59
(-7,81%)
6,34M
DMLDenison Mines Inc
$ 2,66
(-3,27%)
6,16M
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

Delayed Upgrade Clock